Abstract
This article summarizes a continuing education presentation on immunogenicity that was part of a continuing education course entitled, "Clinical Pathology of Biotherapeutics." Immunogenicity of a biotherapeutic can have diverse impacts including altered systemic exposure and pharmacologic responses and, in a fraction of the cases, safety concerns including cross-reactive neutralization of endogenous proteins or sequela related to immune complex disease (ICD). In most cases, immune complexes are readily cleared from circulation; however, based on physiochemical properties, insoluble complexes form, activate complement, and deposit in tissues. Using published information and personal experience, a set of repeat-dose monkey toxicity studies with manifestations suggestive of ICD was reviewed to summarize the spectrum of clinical and pathology findings. The most common live-phase observation linked to ICD was an acute postdosing reaction following multiple dose administrations characterized by generalized collapse and attributed to acute complement activation. Less common live-phase observations were related to syndromes such as a consumptive coagulopathy or a protein losing nephropathy. The most common histologic change attributed ...Continue Reading
References
Jul 1, 1994·Clinical and Diagnostic Laboratory Immunology·K Kuus-ReichelN E Kay
Nov 24, 2001·Blood·J LiD J Kuter
Mar 16, 2002·Blood·Russell L BasserC Glenn Begley
Jan 14, 2005·The Journal of Pharmacology and Experimental Therapeutics·Jeannie R RojasCarrie L Wagner
Oct 30, 2007·Trends in Immunology·Anne S De Groot, David W Scott
Apr 7, 2009·Regulatory Toxicology and Pharmacology : RTP·Rafael PonceDan Wierda
Nov 19, 2013·Toxicologic Pathology·Michael W LeachJoseph C Beyer
Mar 13, 2014·Toxicologic Pathology·Jonathan R HeyenBora Han
Apr 8, 2014·Toxicologic Pathology·Jennifer L RojkoChristopher Horvath
Dec 3, 2014·Journal of Immunological Methods·Piotr PierogBinodh DeSilva
Apr 17, 2015·Cellular Immunology·Liusong YinTimothy P Hickling
Feb 13, 2016·Frontiers in Immunology·Murli Krishna, Steven G Nadler
Jun 19, 2017·Regulatory Toxicology and Pharmacology : RTP·Sven KronenbergFranziska Regenass
Aug 24, 2017·Toxicologic Pathology·Elisabeth HusarGaurav Tyagi
Apr 17, 2018·Current Opinion in Toxicology·Kirsten M MeaseJanice A Lansita
Citations
Apr 23, 2020·Toxicologic Pathology·Lykke BoysenBrian Lauritzen
Dec 5, 2020·Toxicologic Pathology·Richard HaworthMark Price
Nov 22, 2020·Regulatory Toxicology and Pharmacology : RTP·Timothy K MacLachlanCurtis Maier
Jan 19, 2021·Toxicologic Pathology·A Peter HallSydney Mukaratirwa